Skip to main content

Table 3 Prevalence of use of different antihypertensive drug classes in patients with obesity of class I, II and III

From: Utilization of antihypertensive drugs in obesity-related hypertension: a retrospective observational study in a cohort of patients from Southern Italy

  β-blockers ACEIs ARBs CCBs Diuretics α1 adrenergic blockers
Whole population (n = 129) 45 (34.9) 39 (30.2) 55 (42.9) 25 (19.4) 60 (46.9) 7 (5.4)
 Class I (n = 59) 13 (22.0) 25 (42.3) 23 (38.9) 16 (27.1) 26 (44.1) 1 (1.7)
 Class II (n = 34) 19 (55.9) 6 (17.6) 16 (47.1) 5 (14.7) 18 (52.9) 1 (2.9)
 Class III (n = 36) 13 (36.1) 8 (22.0) 16 (44.4) 4 (11.1) 16 (47.1) 5 (13.9)
Only antihypertensive (n = 104) 35 (33.7) 33 (31.7) 45 (43.3) 20 (18.3) 48 (46.2) 4 (3.7)
 Class I (n = 46) 10 (21.7) 18 (39.1) 20 (43.5) 12 (26.1) 21 (45.7) 1 (2.2)
 Class II (n = 29) 14 (48.3) 6 (20.7) 13 (44.8) 4 (13.8) 15 (51.7) 1 (3.4)
 Class III (n = 29) 11 (37.9) 9 (31.0) 12 (41.4) 4 (13.8) 12 (41.4) 2 (6.8)
  1. The numbers in parentheses represent the percentage of the total of the respective group